EdenTree Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$22.6M |
| 2 |
Boston Scientific
BSX
|
+$7.61M |
| 3 |
Broadcom
AVGO
|
+$7.4M |
| 4 |
SUNB
Sunbelt Rentals Holdings
SUNB
|
+$5.68M |
| 5 |
Microsoft
MSFT
|
+$2.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$6.76M |
| 2 |
Merck
MRK
|
+$4.73M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$3.38M |
| 4 |
Avient
AVNT
|
+$2.97M |
| 5 |
Analog Devices
ADI
|
+$1.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 24.45% |
| 2 | Technology | 23.07% |
| 3 | Healthcare | 22.08% |
| 4 | Communication Services | 12.04% |
| 5 | Financials | 12.02% |
No holdings matched the selected filter criteria.
Similar funds
EdenTree Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, EdenTree Asset Management held 67 positions worth $332M, up 1.6% from $326M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
EdenTree Asset Management deployed $30.5M of net new capital in Q1 2026, opening 4 new positions and adding to 12 existing holdings. Its largest new stake was AstraZeneca: 117,184 shares worth $22.7M.
By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 23% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Salesforce, an estimated $6.76M trimmed.
- EdenTree Asset Management's largest Q1 2026 buy was AstraZeneca: 117,184 shares worth $22.7M.
- EdenTree Asset Management added most to Boston Scientific in Q1 2026, an estimated $7.61M increase.
- EdenTree Asset Management's biggest Q1 2026 reduction was Salesforce, cutting an estimated $6.76M.
- EdenTree Asset Management fully exited Paychex in Q1 2026, selling an estimated $449K.
- EdenTree Asset Management's ten largest holdings make up 47% of its $332M portfolio in Q1 2026.
- EdenTree Asset Management opened 4 new positions and closed 2 in Q1 2026.
- EdenTree Asset Management's portfolio value rose 1.6% quarter-over-quarter to $332M.
Based on EdenTree Asset Management's 13F filing for Q1 2026, filed 14 May 2026.